We are close to commercialization, but there is strict gag order in the licensing contract with Abbott, so we will not hear anything about their progress. This was absolutely great for us, because now Abbott will be forced to get this to the market in a hurry. The other thing that will help us is that we now will have help with the point of care test. I Googled us and Inverness and see we are in Investors Business Daily online, Yahoo, MSN, Biospace, and Pharmadeals. We need some television coverage. I would suggest they go back to GE and license the imaging, so we can get on CNBC.